Ensuring Patient Safety With Anti-Counterfeiting and Regulation Reporting

PHOENIX – October 31, 2011 – Axway (NYSE Euronext: AXW), the Business Interaction Networks company, announced today that it will be speaking at the 2nd annual Pharmaceutical Serialization & Traceability Summit in Geneva, Switzerland on November 2-4, 2011. Axway is at the forefront of technological innovations around track and trace technology and will discuss how its technology can be leveraged globally to protect companies and comply with the new coming regulations.

The session, titled “Drug anti-counterfeiting and regulation reporting: how to hit two birds with one stone and benefit patient safety!” will focus on end-to-end visibility of the supply chain and give practical guidance on how manufacturers can cope with complex cross-border regulatory environments. With the World Health Organization estimating that up to one percent of medicines available in the developed world are likely counterfeit, rising to 10 percent globally, there is a clear need for the industry to work together to address the huge risks posed by counterfeit drugs.

“As an active player in international standards and regulation for healthcare, Axway is proud of our pioneering work with leading organizations and pharmaceutical companies,” said Bruno Cambounet, vice president sales and operations, Healthcare EMEA, Axway. “Modern supply chains can be incredibly complex and organisations need complete transparency so that patients aren’t put at risk. Axway’s Track & Trace solution enables organizations to meet regulatory standards – but, at a higher level, we are also committed to helping safeguard supply chains through true visibility that in turn protects the welfare of patients.”

 The Pharmaceutical Serialization & Traceability Summit is being held on November 2-4, 2011 at Crowne Plaza, Geneva, Switzerland. The conference is an opportunity to discuss the latest developments and regulations in pharmaceutical serialization at an international level with leading experts from around the world.

For more information on the Pharmaceutical Serialization & Traceability conference: http://www.pharmaserialisation.com/Event.aspx?id=558904

To schedule a meeting with Axway at the event: http://www.axway.com/events/event/join-axway-pharmaceutical-serialisation-and-traceability-summit-2011

To learn more about Axway’s Track & Trace solutions: http://www.axway.com/products-solutions/integration/track-trace

Read the related case study: AstraZeneca Combats Counterfeit Drugs, Enhances Patient Safety and Protects Brand Integrity with Axway Track & Trace and GS1 EPCIS

Follow Axway on Twitter: http://twitter.com/Axway

About Axway
Axway (NYSE Euronext: AXW), the Business Interaction Networks company, is a software and services company registered in France with headquarters in Phoenix, Arizona.  Established in 2001, Axway serves more than 11,000 organizations in 100 countries, with offices around the globe.  Our award-winning products, solutions and services enable the business-critical transactions required to accelerate performance within and among enterprises – while providing management, security and governance on interactions throughout business networks. Axway’s industry-leading offerings include: business-to-business integration, managed file transfer, secure email, business operations monitoring, process management and identity validation solutions, as well as professional and managed services, cloud solutions, and Software-as-a-Service.  More information is available at www.axway.com.